2019 CNS Meeting: A Preview of Tumor Section Highlights

Constructed with the guiding theme of The Age of Reason for Neurosurgery, the 2019 CNS Annual Meeting in San Francisco, October 18-23, is anticipated to be both an exciting and evidence-based event.

The AANS/CNS Section on Tumors has planned several events of varying formats throughout the 2019 meeting. Our first Tumor Section session, to be held Monday, October 21, 2:45-4:15 pm will tackle the highly relevant topic of complications, both surgical and medicolegal, from the perspective of seasoned luminaries in our field, including Frederick Barker, MD, FAANS; Mitchel Berger, MD, FAANS; William Couldwell, MD, PhD, FAANS; and Daniel Kelly, MD, FAANS as well as moderator Wenya Linda Bi, MD, PhD, and Walavan Sivakumar, MD. High-scoring oral abstract presentations will then follow to complete the session.

To dovetail with the newly minted CNS guidelines for the treatment of brain metastases in adults (visit the website and the Guidelines Session on Tuesday, October 22, 2019, 7 am), our second Tumor Section session on Tuesday, October 22, 2:45-4:15 pm, entitled, “Emerging Concepts in the Management of Brain Metastases,” will highlight the latest evidence-based strategies for treating brain metastases and also confront the significant topics of pseudoprogression, refractory metastases and how precision medicine and immunotherapy are potentially changing our approaches, with leading experts, including Steven Kalkanis, MD, FAANS, and Jennifer Moliterno Gunel, MD, FAANS, and Manmeet Ahluwalia, MD. This session is moderated by Gelareh Zadeh, MD, PhD, FAANS, and Albert Kim, MD, PhD, FAANS. High-scoring oral abstract presentations will follow to complete the session.

The 2019 CNS Tumor Section programming begins on the weekend (October 19 and 20) with six practical courses/symposia on malignant and benign tumor updates, advanced functional mapping, surgery on eloquent areas, 3-D neuroanatomy and stereotactic radiosurgery. Then, throughout the meeting, additional section-specific content can be experienced through case-based sessions, guidelines sessions (on brain metastases and glioblastomas), sunrise sessions, dinner and luncheon seminars covering the management of diverse tumor types, innovative surgical and medical technology and other interactive content.

Mark Rosenblum, MD, FAANS(L), original founding member of the AANS/CNS Section on Tumors, is the honored guest at the Young Neurosurgeons Reception, co-hosted by the AANS Young Neurosurgeons Committee, on Tuesday, October 22, 6:30-8:30 pm. Additional speakers will include the Andrew T. Parsa Research Fellowship winner and the International AANS/CNS Section on Tumors Neuro-Oncology Fellowship recipient.

We look forward to seeing you in San Francisco for an enlightening meeting!